Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "healthCARE"

2866 News Found

Akumentis Healthcare appoints Sachhin Misshra as President
People | April 06, 2026

Akumentis Healthcare appoints Sachhin Misshra as President

With more than two decades of experience, he brings deep expertise in sales, marketing, business transformation, and strategic leadership


Healthcare major QCIL signs solar power pacts with AMPIN and Radiance
Sustainability | April 06, 2026

Healthcare major QCIL signs solar power pacts with AMPIN and Radiance

Phase I to supply clean energy to five facilities, with long-term plans to power 19 hospitals through a 30 MW renewable network


Max Healthcare allots 57,461 equity shares under ESOP 2022
Hospitals | April 05, 2026

Max Healthcare allots 57,461 equity shares under ESOP 2022

Paid-up equity capital rises to Rs 973.19 crore following allotment to eligible employees


Danone India sets record with 20,911 healthcare pledges to fight anemia
Healthcare | April 05, 2026

Danone India sets record with 20,911 healthcare pledges to fight anemia

The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign


FICCI Advantage Healthcare India 2026 honours Fortis Bannerghatta as top kidney transplant centre
Hospitals | April 02, 2026

FICCI Advantage Healthcare India 2026 honours Fortis Bannerghatta as top kidney transplant centre

A key milestone in this journey has been the introduction of TREAT Program, a first-of-its-kind clinical initiative introduced in India


MGM Healthcare builds world’s largest intestinal transplant program in 3 years
Hospitals | March 27, 2026

MGM Healthcare builds world’s largest intestinal transplant program in 3 years

Since launching, the hospital has performed over 40 intestinal transplants, including 21 in 2025 alone


Cadila Pharmaceuticals marks 75-year journey of global healthcare innovation
News | March 16, 2026

Cadila Pharmaceuticals marks 75-year journey of global healthcare innovation

Cadila Pharmaceuticals’ journey has been marked by several milestones, including the development of indigenous formulations, expansion into global markets, and the creation of robust manufacturing and R&D capabilities


APL Healthcare’s Unit-IV classified as VAI by the USFDA
News | March 14, 2026

APL Healthcare’s Unit-IV classified as VAI by the USFDA

This inspection is now closed